Lymphocyte subpopulations in blood and cerebrospinal fluid from patients with subacute sclerosing panencephalitis. 1983

M G Marrosu, and C Cianchetti, and M Tondi, and M G Ennas, and G Marrosu, and M R Murru, and P E Manconi

Lymphocyte subpopulations in peripheral blood (PB) and cerebrospinal fluid (CSF) from 26 children affected with subacute sclerosing panencephalitis (SSPE) and from 13 controls with various neurological diseases without any immunological implication were examined for surface markers. SSPE patients were found to have significantly lower %s of E-rosette forming cells (RFC) (T lymphocytes) and of EA-RFC (TG lymphocytes, suppressor T cells) in both CSF and PB. No difference was found in EAC-RFC (B lymphocytes) either in CSF or PB. The low EA-RFC values can be explained by genetic factors, immune complexes or virus infection, and they could account for the hypersynthesis of oligoclonal immunoglobulins in the central nervous system. Longitudinal studies performed in 6 SSPE patients during isoprinosine therapy revealed a time-dependent decrement of the %s of E- and EA-RFC in CSF. It cannot be affirmed whether this is related to the disease or to the therapy.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007542 Inosine Pranobex An alkylamino-alcohol complex of inosine used in the treatment of a variety of viral infections. Unlike other antiviral agents, it acts by modifying or stimulating cell-mediated immune processes rather than acting on the virus directly. Inosiplex,Methisoprinol,Imunovir,Isoprinosin,Isoprinosine,Methysoprinol,Metisoprinol,NPT-10381,NPT 10381,NPT10381,Pranobex, Inosine
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M G Marrosu, and C Cianchetti, and M Tondi, and M G Ennas, and G Marrosu, and M R Murru, and P E Manconi
January 1994, Polski tygodnik lekarski (Warsaw, Poland : 1960),
M G Marrosu, and C Cianchetti, and M Tondi, and M G Ennas, and G Marrosu, and M R Murru, and P E Manconi
August 2007, Brain & development,
M G Marrosu, and C Cianchetti, and M Tondi, and M G Ennas, and G Marrosu, and M R Murru, and P E Manconi
January 1986, Neurologia i neurochirurgia polska,
M G Marrosu, and C Cianchetti, and M Tondi, and M G Ennas, and G Marrosu, and M R Murru, and P E Manconi
April 1977, Lancet (London, England),
M G Marrosu, and C Cianchetti, and M Tondi, and M G Ennas, and G Marrosu, and M R Murru, and P E Manconi
January 1986, Virologie,
M G Marrosu, and C Cianchetti, and M Tondi, and M G Ennas, and G Marrosu, and M R Murru, and P E Manconi
June 2010, Brain & development,
M G Marrosu, and C Cianchetti, and M Tondi, and M G Ennas, and G Marrosu, and M R Murru, and P E Manconi
January 1992, Neurologia i neurochirurgia polska,
M G Marrosu, and C Cianchetti, and M Tondi, and M G Ennas, and G Marrosu, and M R Murru, and P E Manconi
April 2012, Brain & development,
M G Marrosu, and C Cianchetti, and M Tondi, and M G Ennas, and G Marrosu, and M R Murru, and P E Manconi
October 1982, Polski tygodnik lekarski (Warsaw, Poland : 1960),
M G Marrosu, and C Cianchetti, and M Tondi, and M G Ennas, and G Marrosu, and M R Murru, and P E Manconi
September 2009, Pediatric neurology,
Copied contents to your clipboard!